EN
HI

THYROCARE TECH Share price

THYROCARE

HealthcareMid

952.8

43.90 (-4.40%)
NSE
BSE
Last updated on 6 Jun, 2025 | 15:49 IST
BUYSELL
Today's High

995.50

Today's Low

874.10

52 Week Low

571.40

52 Week High

1073.20

The current prices are delayed, login to your account for live prices

Thyrocare Technologies Chart

THYROCARE TECH Fundamentals

P/E Ratio

57.7

P/B Ratio

9.66

Div. Yield

2.11

Sector P/E

48.61

Sector P/B

4.4

Sec. Div. Yield

0.17

THYROCARE TECH Resistance and Support

Pivot 1002.23

Resistance

First Resistance

1018.46

Second Resistance

1040.23

Third Resistance

1056.46

Support

First Support

980.46

Second Support

964.23

Third Support

942.46

THYROCARE TECH Futures & Options

Data Not Found

THYROCARE TECH Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    71.06%

    Mutual Fund

    12.75%

    Insurance

    1.06%

    Foreign Institutional Investors

    2.77%

    Domestic Institutional Investors

    0.86%

    Retail

    11.5%

    Others

    0%

    Total Promoters
    MAR '24
    71.11%
    JUN '24
    71.11%
    SEP '24
    71.11%
    DEC '24
    71.06%

    THYROCARE TECH Corporate Actions

    DateAgenda
    2025-04-23Audited Results & Final Dividend
    2025-01-23Quarterly Results
    DateEvent TypeAgenda
    2025-04-23Board MeetingAudited Results & Final Dividend
    2025-01-23Board MeetingQuarterly Results

    THYROCARE TECH News

    Thyrocare Technologies shares soar nearly 17% as Q1 results impress D-Street

    Jul 24 2024 14:41:59
    Read More

    About THYROCARE TECH AboutThe

    NSE : 17032  
    BSE : 539871  
    ISIN : INE594H01019  

    The Company was incorporated as Thyrocare Technologies Limited on January 28 2000 at Mumbai as a public limited company under the Companies Act 1956. the Company was issued a certificate of commencement of business from the RoC on March 7 2000. Major events and milestones of the Company :2000-The Company was incorporated in the name and style of "Thyrocare Technologies Limited? and received a certificate for commencement of operations. 2001-The Company received ISO 9001 certification. -The Company commenced commercial operations under the brand name 'Thyrocare' pursuant to the acquisition of business of TDPL and TBPL (which were incorporated in 1996). 2005-The Company received NABL accreditation. 2006-The Company issued certain fully convertible debentures aggregating to 250 million to BCCL. 2007-The Company receives accreditation from the College of American Pathologists (CAP). 2010-The Company issued certain compulsorily convertible debentures aggregating to 250 million to Agalia. Agalia also acquired certain Equity Shares aggregating to 1250 million from the Promoters and certain other persons. -The Company launched wellness packages under the brand name "Aarogyam". 2011-The Company migrated to "total laboratory automation system" installed by Siemens for efficient handling of increasing volumes. 2012-NVP acquired certain Equity Shares aggregating to 1200 million from certain entities. 2013-EIF acquired certain Equity Shares from Agalia. -The Subsidiary commenced operations at the PET-CT centres at Navi Mumbai and conducted over 1000 scans in the first year of operation. 2014-The Company had installed India?s first and the world?s longest track automation system for seamless sample movements from Siemens Limited. -The Company commissioned the operations in medical cyclotron facility in Navi Mumbai. -The Subsidiary commenced operations at the PET-CT centres in New Delhi and Hyderabad and the PET-CT centres at New Delhi conducted over 1000 scans in the first year of operations. 2015-The Company opened RPLs in Delhi Coimbatore Hyderabad and Kolkata to expand its coverage and volume of tests and samples processed daily. -The Company acquired the equipment for testing of water samples and commenced operating the equipment under the brand name "WHATERS". These tests at present include physical and chemical testing elements testing microbiology testing pesticide testing and volatile organic compounds testing. -The Subsidiary has completed over 10000 scans at the PET-CT centres in New Delhi over 10000 scans at the PET-CT centres in Navi Mumbai from the date of inception and over 1000 scans at the PET-CT centres in Hyderabad since inception.

    THYROCARE TECH Management

    NamePosition
    Mr. Rahul Guha Managing Director & CEO
    Mr. Dharmil Sheth Non Executive Director
    Mr. Hardik Dedhia Non Executive Director
    Mr. Dhaval Shah Non Executive Director
    Mr. Gopalkrishna Shivram Hegde Independent Director
    Read More

    THYROCARE TECH FAQs

    THYROCARE TECH शेयर का खरीद मूल्य 952.8 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    THYROCARE TECH शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    THYROCARE TECH शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 57.7 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    THYROCARE TECH शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 9.66 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    THYROCARE TECH शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.4 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    THYROCARE TECH का मार्केट कैप 5049.22 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    THYROCARE TECH शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 1073.20 और 571.40 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    THYROCARE TECH Share Key Metrics

    Volume
    2.03 L
    Market Cap
    5049.22 CR
    LTQ@LTP
    1@952.80
    ATP
    948.27
    Var Margin
    75 %
    Circuit Range
    797.4-1196
    Delivery %
    43.92 %
    Value
    19.29 CR
    ASM/GSM
    No
    Market Lot
    1